Abstract
As the human cannabinoid (CBD) market grows, there is an inevitable transfer of the same or similar products into the veterinary sector. Advances in veterinary medicine and care of companion animals has led to extended life expectancy and consequently, there is an increased incidence of age-related chronic conditions that compromise quality of life. CBD products may alleviate these conditions. Research into CBD for companion animal species is on the rise, however, we found that there are no licensed veterinary CBD products available in the market due to a lack of appropriate testing and/or data. Here we outline the data that is available and show that the regulatory, and safety considerations around these products needs further consideration and this encompasses many products currently available on the market. Changes in regulations and further research for quality assurance are paramount to distribution of safe and applicable products for companion animals.
